Deficiencies in the death receptor-mediated pathway of extrinsic apoptosis, such as mutations in Fas or FasL, have been associated with autoimmune lymphoproliferative syndrome (ALPS) in both humans [3, 4] and mice [5, 6] due to inefficient clearing of antigen-activated T cells. Here, FASLG is linked to autoimmune lymphoproliferative syndrome.